申请人:Neuropharma S.A.
公开号:EP1939191A1
公开(公告)日:2008-07-02
The present invention relates to furan derivatives of formula (I), their method of synthesis and uses thereof. Concretely, the compounds disclosed have proved to be inhibitors of glycogen synthase kinase 3β, GSK-3 β, which is known to be involved in different disease and conditions, such as Alzheimer's disease or non-insulin dependent diabetes mellitus. The present invention also relates to pharmaceutical compositions comprising the same. Further, the present invention is directed to the use of the compounds in the manufacture of a medicament for the treatment and/or prevention of a GSK-3 mediated disease or condition.
本发明涉及式(I)的呋喃衍生物,其合成方法及用途。具体来说,所披露的化合物已被证明是糖原合成酶激酶3β(GSK-3β)的抑制剂,GSK-3β已知参与不同疾病和病况,如阿尔茨海默病或非胰岛素依赖型糖尿病。本发明还涉及包含这些化合物的药物组合物。此外,本发明旨在将这些化合物用于制造治疗和/或预防GSK-3介导的疾病或病况的药物。